Post-ASH 2021 International Workshop on Myeloproliferative Neoplasms (iwMPNs) (VJHemOnc) - Jan 8, 2022 - Pres time: Jan 28, 2022; 12:30 PM - 03:33 PM; "1:12 PM - 1:55 PM, Treatment of Myelofibrosis Patients with the TGF-β 1/3 Inhibitor AVID200 (MPN-RC 118) Induces a Profound Effect on Platelet Production; Discussion - panellist: John Mascarenhas; 2:33 PM - 3:33 PM, A Randomized Open-Label, Phase 3 Study to Evaluate Imetelstat Versus Best Available Therapy (BAT) in Patients with Intermediate-2 (Int-2) or High-Risk Myelofibrosis (MF) Refractory to Janus Kinase Inhibitor (JAKi); Discussion - panellist: John Mascarenas."
Live event
|